Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 25, 2019

Patent Application Number

15029420

Date Filed

October 21, 2014

Patent Citations Received

US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

US Patent 11518772 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

US Patent 11518758 Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof

US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

US Patent 11390611 Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof

US Patent 12071432 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

0

US Patent 11530206 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

US Patent 10858359 Heterocyclic ring derivatives useful as SHP2 inhibitors

...

Patent Primary Examiner

Patent abstract

The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool